| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/17/2008 | US20080171046 Novel proteins and nucleic acids encoding same |
| 07/17/2008 | US20080171038 Methods of treating idiopathic thrombocytopenia purpura using a gm-csf antagonist |
| 07/17/2008 | US20080171036 Using tumor necrosis factor specific immuoglobulin for diagnosis, treatment and prevention of inflammatory, cell proliferative, skin, respiratory system, nervous system and infectious disorders |
| 07/17/2008 | US20080171021 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 07/17/2008 | DE10254072B4 Verwendung von Vitex agnus-castus als Repellent gegen Zecken und/oder Milben Vitex agnus castus used as a repellent against ticks and / or mites |
| 07/17/2008 | CA2675029A1 Pharmaceutically active compounds |
| 07/17/2008 | CA2674998A1 Pyridine compounds and their use as p2y12 antagonists |
| 07/16/2008 | EP1944298A1 Quinazoline derivative and pharmaceutical |
| 07/16/2008 | EP1944034A1 Adsorbent for advanced glycation endproducts |
| 07/16/2008 | EP1944027A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |
| 07/16/2008 | EP1942911A1 Therapeutic molecules and their uses |
| 07/16/2008 | EP1942895A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 07/16/2008 | EP1476541B1 Cytokine (zcytor17 ligand) |
| 07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
| 07/16/2008 | CN101223167A Novel heteroaryl fused cyclic amines |
| 07/16/2008 | CN101220028A Urea substituted imidazopyridines |
| 07/16/2008 | CN101219994A Ozagrel ester, composition and production method thereof |
| 07/16/2008 | CN101219153A Maggot tegument refuse removing anti thrombosis |
| 07/16/2008 | CN101219151A Bicarbonate-based solutions for dialysis therapies |
| 07/16/2008 | CN101219133A Levorotation carnitine pellet and method for preparing the same |
| 07/16/2008 | CN101219132A Method for applying calcium polyenoic acid for medical and beauty treatment fields |
| 07/16/2008 | CN101219131A Method for applying calcium polyenoic acid for medical and beauty treatment fields |
| 07/16/2008 | CN101219114A Pennogenin compounds solid state molecule dispersion preparation |
| 07/16/2008 | CN100402642C Method and apparatus or maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 07/16/2008 | CN100402528C Urea substituted imidazopyridines |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/16/2008 | CN100402496C Compounds useful as matrix metalloprotease inhibitors |
| 07/16/2008 | CN100402042C Composition and method for augmenting kidney function |
| 07/16/2008 | CN100402025C Modified release pharmaceutical formulation |
| 07/16/2008 | CN100402024C Gingko lactone freeze dried powder injection and its preparation method |
| 07/16/2008 | CN100401912C Slowly digestable starch product |
| 07/15/2008 | US7399878 Pharmaceutical compounds |
| 07/15/2008 | US7399829 Variants of RANKL protein |
| 07/15/2008 | US7399604 Methods and products related to evaluating the quality of a polysaccharide |
| 07/15/2008 | US7399471 Diagnosis of RH factor; using polypeptides to form antibodies; purified polypeptide capable of forming antigen binding structures with specificity for Rhesus D antigens for treating idiopathic thrombocytopenic purpura (ITP) or mistransfusion of Rhesus incompatible blood |
| 07/15/2008 | US7399464 Polypeptides of the IFNα-7 gene |
| 07/15/2008 | CA2362271C Essential fatty acids in the prevention of cardiovascular events |
| 07/15/2008 | CA2274149C Peptides and compounds that bind to a receptor |
| 07/15/2008 | CA2250861C Cyclic adhesion inhibitors |
| 07/10/2008 | WO2008082669A2 Von willebrand factor- and factor viii-polymer conjugates having a releasable linkage |
| 07/10/2008 | WO2008082658A2 Cyclitols and their derivatives and their therapeutic applications |
| 07/10/2008 | WO2008082613A2 Factor ix moiety-polymer conjugates having a releasable linkage |
| 07/10/2008 | WO2008082542A1 Combination of vitamin k and vitamin k antagonist such as r-isomer of warfarin, phenprocoumon or r-isomer of phenprocoumon as anticoagulant therapy |
| 07/10/2008 | WO2008082321A1 Emulsion of perfluoroorganic compounds for medical use and a methods for the preparation and the use thereof |
| 07/10/2008 | WO2008081116A2 Cellular preparations for use as a revascularisation stimulating agent |
| 07/10/2008 | WO2008081024A1 Subcutaneous administration of coagulation factor viia-related popypeptdes |
| 07/10/2008 | WO2008080973A1 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 07/10/2008 | WO2008080972A1 Substituted oxindole derivative and its use as a vasopressin receptor modulator |
| 07/10/2008 | WO2008080971A1 Substituted oxindole derivative and its use as a vasopressin receptor ligand |
| 07/10/2008 | WO2008080970A1 Substituted oxindole derivative and its use as a vasopressin receptor ligand |
| 07/10/2008 | WO2008020743A3 Method for extracting a platelet aggregation inhibitor from agkistrodon blomhoffii ussuriensis venom |
| 07/10/2008 | WO2008020742A3 Method for extracting fibrinogenic/fibrinolytic protein from agkistrodon blomhoffii ussuriensis venom |
| 07/10/2008 | US20080167609 Methods of treating vascular disease |
| 07/10/2008 | US20080167381 5-Amino-4-Hydroxy-2-Isopropyl-7-[4-Methoxy-3-(3-Methoxypropoxy)Benzyl]-8-Methylnonamides |
| 07/10/2008 | US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors |
| 07/10/2008 | US20080167341 1H-Benzimidazol-2-yl methyl)-piperidin-3-ylmethyl-(5,6,7,8-tetrahydro-quinolin-8-yl)-amine; fusin and chemokine receptors antagonist/agonist; increase progenitor and/or stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 07/10/2008 | US20080167318 Pharmaceutically active pyrrolidine derivatives |
| 07/10/2008 | US20080167283 Nandrolone 17 Beta-Carbonates |
| 07/10/2008 | US20080167266 Process For Preparing An Iron Saccharose Complex |
| 07/10/2008 | US20080167243 immunizing a subject with a sufficient amount of a translated polypeptide to produce antibody; containing a phenylalanine or tyrosine derivative analoges |
| 07/10/2008 | US20080167241 Mu-1, member of the cytokine receptor family |
| 07/10/2008 | US20080167240 Albumin Fusion Proteins |
| 07/10/2008 | US20080167239 Albumin Fusion Proteins |
| 07/10/2008 | US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies |
| 07/10/2008 | US20080166783 In vivo incorporation of unnatural amino acids |
| 07/10/2008 | US20080166387 Anti-angiogenic compositions and methods of use |
| 07/10/2008 | CA2673584A1 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 07/10/2008 | CA2672021A1 Factor ix moiety-polymer conjugates having a releasable linkage |
| 07/10/2008 | CA2670654A1 Cellular preparations for use as a revascularisation stimulating agent |
| 07/09/2008 | EP1942186A2 Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use |
| 07/09/2008 | EP1941890A1 Hematopoietic stem cell proliferator |
| 07/09/2008 | EP1941867A1 Prevention and reduction of blood loss |
| 07/09/2008 | EP1940400A2 Use of enoxaparin for performing percutaneous coronary intervention |
| 07/09/2008 | EP1940399A2 Use of par-i/par- 4 inhibitors for treating or preventing vascular diseases |
| 07/09/2008 | EP1940379A2 Methods for treatment of hemorrhagic shock and related disorders |
| 07/09/2008 | EP1727553B1 Agent for substitution of blood plasma and a method of its production |
| 07/09/2008 | EP1534289B1 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 07/09/2008 | EP1385499B1 Use of carnitine for the preparation of an injection solution for preventing or alleviating ascites in poultry by in-ovo injection |
| 07/09/2008 | EP1207891B1 Use of a low molecular weight sulphated polysaccharide in the treatment of thrombosis |
| 07/09/2008 | EP0959878B1 Method for treating renal failure |
| 07/09/2008 | CN101218227A Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 07/09/2008 | CN101215549A In vitro reforming method for erythrocyte blood type and special-purpose assorted agent for the same |
| 07/09/2008 | CN101215286A Tricyclic androgen receptor modulator compounds and methods |
| 07/09/2008 | CN101214374A Preparations with procoagulant and hemostasis function |
| 07/09/2008 | CN101214315A Medicament for preventing and treating gynaecologic hemorrhage and preparation thereof |
| 07/09/2008 | CN101214294A Effective fraction with blood nourishing function of potentilla anserine and extracting method |
| 07/09/2008 | CN101214289A Chinese medicinal composition for treating thrombocytopenic purpura and preparation thereof |
| 07/09/2008 | CN101214263A Method for preparing freeze-dried powder containing bacillus natto and nattokinase |
| 07/09/2008 | CN101214251A Pennogenyl saponins compounds percutaneously absorbable preparation |
| 07/09/2008 | CN101214046A Method for preparing ginkgo biloba oil powder |
| 07/09/2008 | CN100400548C Fusional protein with intensified activity of internal red-blood-cell formation element |
| 07/09/2008 | CN100400100C Methods for preventing or attenuating patthoangiogenic conditions |
| 07/09/2008 | CN100400075C Qi-invigorating, blood-nourishing medicinal composition and its preparing method |
| 07/09/2008 | CN100400035C Clopidogrel sulfate solid preparation, and its preparing method |
| 07/08/2008 | US7396931 Clopidogrel sulfate by reacting a first solvent solution of clopidogrel with sulfuric acid, adding a second solvent to precipitate the salt, and filtering; first and second solvents are acetone and diisopropyl ether or dichloromethane and either diisopropyl ether, cyclohexane or ethyl acetate |
| 07/08/2008 | US7396859 Perturbed membrane-binding compounds |
| 07/08/2008 | US7396851 Heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin A for the treatment of β-thalassaemia |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | CA2445620C Tetracyclic compounds as pde5-inhibitors |